Burning Rock Biotech (BNR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Burning Rock Biotech Limited is set to delist its American Depositary Shares (ADSs) from the London Stock Exchange due to low trading volume and high maintenance costs, with an anticipated effect date around September 18, 2024. However, the company’s ADSs will remain available for trading on the Nasdaq Global Market. This move reflects Burning Rock’s strategic adjustments in response to market conditions while continuing their focus on next generation sequencing technology in precision oncology.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.
